New hope for liver cancer: immunotherapy and radiation before surgery shows promise
NCT ID NCT07075120
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This study tests a new approach for people with locally advanced liver cancer that is hard to remove with surgery alone. Participants will receive two immunotherapy drugs (ipilimumab and nivolumab) along with targeted radiation, followed by surgery if the tumor shrinks enough. The goal is to see if this combination is safe and can help more patients become eligible for curative surgery, especially in Native Hawaiian and Pacific Islander communities who are often underrepresented in research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Queen's Medical Center
RECRUITINGHonolulu, Hawaii, 96813, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Hawai'i Cancer Center
NOT_YET_RECRUITINGHonolulu, Hawaii, 96813, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.